Intravenous infusion of engineered megakaryocytes to produce oncolytic platelets in vivo for enhanced cancer immunotherapy
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
Proceedings of the National Academy of Sciences, Volume 123, Number 7, February 2026.
ImportanceOncolytic viruses (OVs) are emerging as promising anticancer treatments that selectively kill tumor cells and induce antitumor immunity. However, the therapeutic efficacy of OV via systemic administration is limited by antibody-mediated…
